Resumen
Genomic instability is a key feature of cancer. Chromosomal rearrangements and segmental DNA copy-number alterations in the tumor genome lead to aberrant gene expression pattern. Array-based comparative genomic hybridization (aCGH) is a molecular cytogenetic technique designed to measure DNA copy-number status and identify segmental dosage alterations. The emergence of aCGH technology is placed into context in the evolution of molecular cytogenetics. The defining characteristics of contemporary genomic array platforms are reviewed, and the material considerations for using these platforms are explained. This chapter describes the development and current knowledge on aCGH technology and its role in cancer research and clinical diagnostics.
Idioma original | English |
---|---|
Título de la publicación alojada | Molecular Testing in Cancer |
Editorial | Springer New York |
Páginas | 27-37 |
Número de páginas | 11 |
ISBN (versión digital) | 9781489980502 |
ISBN (versión impresa) | 1489980490, 9781489980496 |
DOI | |
Estado | Published - oct. 1 2013 |
Publicado de forma externa | Sí |
Nota bibliográfica
Publisher Copyright:© 2014 Springer Science+Business Media New York. All rights are reserved.
ASJC Scopus Subject Areas
- General Medicine